Literature DB >> 3883168

Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.

B Fisher, C Redmond, E R Fisher, M Bauer, N Wolmark, D L Wickerham, M Deutsch, E Montague, R Margolese, R Foster.   

Abstract

In 1971 we began a randomized trial to compare alternative local and regional treatments of breast cancer, all of which employ breast removal. Life-table estimates were obtained for 1665 women enrolled in the study for a mean of 126 months. There were no significant differences among three groups of patients with clinically negative axillary nodes, with respect to disease-free survival, distant-disease--free survival, or overall survival (about 57 per cent) at 10 years. The patients were treated by radical mastectomy, total ("simple") mastectomy without axillary dissection but with regional irradiation, or total mastectomy without irradiation plus axillary dissection only if nodes were subsequently positive. Similarly, no differences were observed between patients with clinically positive nodes treated by radical mastectomy or by total mastectomy without axillary dissection but with regional irradiation. Survival at 10 years was about 38 per cent in both groups. Our findings indicate that the location of a breast tumor does not influence the prognosis and that irradiation of internal mammary nodes in patients with inner-quadrant lesions does not improve survival. The data also demonstrate that the results obtained at five years accurately predict the outcome at 10 years. We conclude that the variations of local and regional treatment used in this study are not important in determining survival of patients with breast cancer.

Entities:  

Mesh:

Year:  1985        PMID: 3883168     DOI: 10.1056/NEJM198503143121102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  149 in total

1.  A sentinel node biopsy in breast cancer patients.

Authors:  T Ikeda
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Management of breast cancer: what do I tell the patient?

Authors:  C J Wright
Journal:  Can Fam Physician       Date:  1986-01       Impact factor: 3.275

3.  Immunohistochemical Detection of p53 and c-erbB-2 Proteins: Prognostic Significance in Operable Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1994-07-30       Impact factor: 4.239

4.  Controversies in the Surgical Management of Operable Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

5.  Failure of routine axillary nodal sampling to predict survival outcomes in lymph node-negative (N0) breast cancer.

Authors:  Kirby I Bland
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

6.  Role of axillary lymph-node dissection in the management of breast cancer.

Authors:  Marvin J Wexler
Journal:  Can J Surg       Date:  2003-08       Impact factor: 2.089

7.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 8.  The detection of circulating breast cancer cells in blood.

Authors:  A M Gilbey; D Burnett; R E Coleman; I Holen
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

Review 9.  Negotiating criteria and setting limits: the case of AIDS.

Authors:  M A Cutter
Journal:  Theor Med       Date:  1990-09

10.  Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast.

Authors:  Andrew J Creager; Kim R Geisinger; Nancy D Perrier; Perry Shen; Jo Ann Shaw; Peter R Young; Doug Case; Edward A Levine
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.